Fig. 6
From: COVID-19 epidemic modelling for policy decision support in Victoria, Australia 2020–2021
Outbreak analysis in Victoria in 2021, over 90 days starting from a single case and different levels of population vaccine coverage. Left: AstraZeneca type vaccine, with assumed protection against infection of 50%, and protection against symptomatic disease of 65%. Right: Pfizer type vaccines, with assumed protection against infection of 80%, and protection against symptomatic disease of 90%. TPOD = total protection against disease; POI = protection against infection. Note that vaccine efficacy estimates were based on best available data as at March 2021